Iridoplasty for plateau iris syndrome: a systematic review

被引：10

作者：

Bourdon, Hugo ^{[1
,2
]}

Aragno, Vittoria ^{[1
,2
]}

Baudouin, Christophe ^{[1
,3
]}

Labbe, Antoine ^{[1
,3
]}

机构：

[1] CHNO, III, Paris, France

[2] Hop Ambroise Pare, Ophthalmol, Boulogne, France

[3] CHNO, INSERM, DGOS Clin Invest Ctr, CIC 1423, Paris, France

来源：

BMJ OPEN OPHTHALMOLOGY | 2019年 / 4卷 / 01期

关键词：

Glaucoma; Iris; Treatment Lasers; LASER PERIPHERAL IRIDOPLASTY; PRIMARY ANGLE-CLOSURE; MANAGEMENT; PREVALENCE; IRIDOTOMY; GLAUCOMA;

D O I：

10.1136/bmjophth-2019-000340

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Plateau iris syndrome (PIS) is a frequent cause of angle closure. Argon laser peripheral iridoplasty (ALPI) has been proposed in PIS to widen the iridocorneal angle. The objective of the present study was to perform a systematic review of the available studies evaluating the efficacy of ALPI on intraocular pressure (IOP), iridocorneal angle opening and the number of medications in patients with chronic angle-closure associated with PIS. One prospective and seven retrospective studies with a minimum 1 month of follow-up were included. Although ALPI seemed to lower IOP, to decrease the number of topical antiglaucoma medications and widen the iridocorneal angle shortly after the procedure, there is no current evidence of long-term efficacy. To date, there is no robust scientific evidence to advocate ALPI as a treatment for chronic angle-closure caused by PIS.

引用

页数：7

共 25 条

[1]

American Academy of Ophthalmology, 2012, BAS CLIN SCI COURS G, P2004

[2] Urrets-Zavalia syndrome as a complication of argon laser peripheral iridoplasty [J].